Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Extended Regimen Yaz for Contraception
NCT00266032Phase 3Completed
- Sponsor
- Bayer
- Start
- Dec 2005
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, open-label trial of ethinyl estradiol + drospirenone in contraception (3 arms), sponsored by Bayer. Primary endpoints: Number of Days With Bleeding Including Spotting at 1 year, Number of Unintended Pregnancies in Yaz Flexible Arm at 2 years and 3 more. Started Dec 2005; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00266032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00266032.